Treatment of erythrocytosis associated with obesity hypoventilation syndrome.
Mascitelli
Luca
L
Pezzetta
Francesca
F
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007040:Hypoventilation / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D020738:Leptin / Q000502:physiology; D009765:Obesity / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D012121:Respiration, Artificial; D012137:Respiratory System / Q000503:physiopathology; D020181:Sleep Apnea, Obstructive / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D013577:Syndrome; D015431:Weight Loss
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D020738:Leptin